|
3721 |
Protocol of the TREASURE study: Thoracic RadiothErapy with Atezolizumab in Small cell lUng canceR Extensive disease – a randomized, open-label, multicenter phase II trial
Enthalten in BMC cancer Bd. 22, 24.9.2022, Nr. 1, date:12.2022: 1-9
|
|
|
|
3722 |
Public microarray repository semantic annotation with ontologies employing text mining and expression profile correlation
Enthalten in BMC bioinformatics Bd. 9, 30.10.2008, Nr. 10, date:10.2008: 1-2
|
|
|
|
3723 |
Publisher Correction: TIGIT and PD-L1 co-blockade promotes clonal expansion of multipotent, non-exhausted antitumor T cells by facilitating co-stimulation
Enthalten in Nature cancer Bd. 6, 17.1.2025, Nr. 2, date:2.2025: 405
|
|
|
|
3724 |
pulver: an R package for parallel ultra-rapid p-value computation for linear regression interaction terms
Enthalten in BMC bioinformatics Bd. 18, 29.9.2017, Nr. 1, date:12.2017: 1-8
|
|
|
|
3725 |
PUMA, antiProton unstable matter annihilation
Enthalten in The European physical journal / A / Hadrons and nuclei Bd. 58, 4.5.2022, Nr. 5, date:5.2022: 1-69
|
|
|
|
3726 |
Pumpless extracorporeal interventional lung assist in patients with acute respiratory distress syndrome: a prospective pilot study
Enthalten in Critical care Bd. 13, 30.1.2009, Nr. 1, date:2.2009: 1-7
|
|
|
|
3727 |
pyHiM: a new open-source, multi-platform software package for spatial genomics based on multiplexed DNA-FISH imaging
Enthalten in Genome biology Bd. 25, 13.2.2024, Nr. 1, date:12.2024: 1-11
|
|
|
|
3728 |
Q-HAM: a multicenter upfront randomized phase II trial of quizartinib and high-dose Ara-C plus mitoxantrone in relapsed/refractory AML with FLT3-ITD
Enthalten in Trials Bd. 24, 15.9.2023, Nr. 1, date:12.2023: 1-15
|
|
|
|
3729 |
Quantum-limited measurements of intensity noise levels in Yb-doped fiber amplifiers
Enthalten in Applied physics / B / Lasers and optics Bd. 126, 9.7.2020, Nr. 8, date:8.2020: 1-7
|
|
|
|
3730 |
Questionnaire-based detection of immune-related adverse events in cancer patients treated with PD-1/PD-L1 immune checkpoint inhibitors
Enthalten in BMC cancer Bd. 21, 24.3.2021, Nr. 1, date:12.2021: 1-10
|
|
Administration
